Increased salt retention and hypertension from non-steroidal agents in the elderly

QJM: An International Journal of Medicine

Volumn 90, Issue 6, 1997, Pages 411-415

  Mulkerrin, E C ^a   Clark, B A ^a   Epstein, F H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; SALT LOADING; SODIUM RETENTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 0030913833     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.6.411     Document Type: Article

References (42)

1. Hypertension prevalence and the status of awareness, treatment, and control in the United States: Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension 1985; 7:457-68.
2. Freeman DH Jr., Ostfield AM, Hellenbrand K, Richards VA, Trace R. Changes in the prevalence distribution of hypertension: Connecticut adults 1978-79 to 1982. J Chronic Dis 1985; 38:157-64.
3. Hulley SB, Furberg CD, Gurland B, McDonald R, Perry HM, Schnaper HW, Schoenberger JA, Smith WM, Vogt TM. The systolic hypertension in the elderly program (SHEP): Antihypertensive efficacy of chlorothalidone. Am J Cardiol 1985; 56:913-20.
4. Simpson FO. Blood pressure and sodium intake. In: Bulpitt CJ, ed. Handbook of hypertension: epidemiology of hypertension, vol 6. Amsterdam, Elsevier, 1985:175-90.
5. Gleibermann L. Blood pressure and dietary salt in human populations. Ecol Food Nutr 1973; 2:143-56.
6. McCarron DA, Henry HJ, Morris CD. Human nutrition and blood pressure regulation: an integrated approach. Hypertension 1982; 4(Suppl III):2-13.
7. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium. Br Med J 1988; 297:319-28.
8. Elliott P, Stamler J, Nichols R, Dryer AR, Stamler R, Kesteloot H, Marmot M for the Intersalt Cooperative Research Group. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. Br Med J 1996; 312:1248-53.
9. Strauss MB, Lamdin E, Smith WP, Bleifer DJ. Surfeit and deficit of sodium. Arch Intern Med 1958; 102:527-36.
10. Epstein M, Hollenberg NK. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87:411-17.
11. Crane MG, Harris JJ, Johns VJ. Hyporeninemic Hypertension. Am J Med 1972; 52:457-66.
12. Crane MG, Harris JJ. Effect of aging on renin activity and aldosterone excretion. J Lab Clin Med 1976; 87:949-59.
13. Noth RH, Lassman MN, Tan SYM, et al. Age and the renin-aldosterone system. Arch Intern Med 1977; 137:1414-17.
14. Weidmann P, Beretta-Piccoli C, Ziegler WH, et al. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels - studies in normal subjects and in patients with essential hypertension. Kidney Int 1978; 14:619-28.
15. Weidmann P, DeMyttenaere-Bursztein S, Maxwell MH, Lima Jose De, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975; 8:325-33.
16. Hollander W, Judson WE. Electrolyte and water excretion in arterial hypertension. I. Studies in non-medically treated subjects with essential hypertension. J Clin Invest 1957; 36:1460-9.
17. Baldwin DS, Biggs AW, Goldring W, Hulet WH, Chasis H. Exaggerated natriuresis in essential hypertension. Am J Med 1958; 24:893-902.
18. Papper S, Belsky JL, Bleifer KH. The response to the administration of an isotonic sodium chloride-lactate solution in patients with essential hypertension. J Clin Invest 1960; 39:876-84.
19. Buckalew VM Jr., Puschett JB, Kintzel JE, Goldberg M. Mechanism of exaggerated natriuresis in hypertensive man: impaired sodium transport in the loop of Henle. J Clin Invest 1969; 48:1007-16.
20. Krakoff LR, Goodwin FJ, Baer L, Torres M, Laragh JH. The role of renin in the exaggerated natriuresis of hypertension. Circulation 1970; 42:335-45.
21. Pedersen EB. Effect of sodium loading and exercise on renal haemodynamics and urinary sodium excretion in young patients with essential hypertension before and during propranolol treatment. Acta Med Scand 1977; 201:365-73.
22. Matsubara H, Umeda Y, Yamaney ?, Nishikawa M, Taniguchit, Inada M. Role of atrial natriuretic polypeptides for exaggerated natriuresis in essential hypertension. Am J Cardiol 1987; 60:708-14.
23. Schalekamp MADH, Krauss XH, Schalekamp-Kuyken MPA, Kolsters G, Birkenhager WH. Studies on the mechanism of hyper-natriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function. Clin Sci 1971; 41:219-31.
24. Frolich JC, Wilson TW, Sweetman BJ, et al. Urinary prostaglandins: Identification and origins. J Clin Invest 1975; 55:763-70.
25. Kuhlik A, Elahi D, Epstein FH, Clark BA. Decline in urinary excretion of dopamine and PGE2 with age. Ger Nephl Urol 1995; 5:79-83.
26. Granthan JJ, Orloff J. Affect of prostaglandin E2 in the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′ 5′ monophosphate and theophylline. J Clin Invest 1968; 47:1154-8.
27. Dunn MJ. Renal prostaglandins. In Klahr S, ed Contemporary Nephrology, vol 4. Plenum Publishing, 1987:133-94.
28. Larsson C, Weber P, Anggard E. Arachidonic acid increases and indomethacin decreases plasma renin activity in rabbits. Eur J Pharmacol 1974; 28:391-94.
29. Nasjletti A. The role of arachidonic acid metabolism in the modulation of renal blood flow. In: MJ Dunn, C Patrono, G Cinotti, eds. Prostaglandins and the Kidney, New York, Plenum Publishers, 1983:111-18.
30. Stokes JB, Kokko JP. Inhibitors of sodium transport by PGE2 across the isolated, perfused rabbit collecting tubule. J Clin Invest 1977; 59:1099-104.
31. Vinci JM, Horwitz D, Zusman RM, et al. The effect of converting enzyme inhibition with SQ 20881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension 1979; 1:416-26.
32. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 1950; 28:496-507.
33. Koch-Weser J. Correlation of pathophysiology and pharmacology in primary hypertension. Am J Cardiol 1973; 32:499-508.
34. Tarazi RC, Magrini F, Dustan HP. The role of aortic distensibility in hypertension. In: Milliez P, Safer M, eds. Recent advances in hypertension, vol II. Reims, Boehringer Ingelheim, 1975:1875:113.
35. Weller RO. Vascular pathology in hypertension. Age Ageing 1979; 8:104-9.
36. Editorial. Cells, ions, and blood pressure. Lancet 1982; 2:965-7.
37. +-ATPase) activity in healthy men. J Gerontol 1983; 38:23-5.
38. + co-transport in elderly hypertensive subjects. Isr J Med Sci 1985; 121:314-16.
39. Ohasi M, Fujio N, Nawata H, et al. High plasma concentration of human atrial natriuretic polypeptide in aged men. J Clin Endocrin Metab 1987; 64:81-5.
40. Mulkerrin EC, Brain A, Hampton D, Penney MD, Sykes DA, Williams JD, Cole GA, Woodhouse KW. Reduced renal haemodynamic response to atrial natriuretic peptide in elderly volunteers. Am J Kidney Dis 1993; 22(4):538-44.
41. Tan AC, Jansen TL, Thien T, Kloppenberg PW, Benraad TJ. Comparison of cyclic guanosine monophosphate 8 response to infusion of atrial natriuretic peptide infusion in young and elderly subjects. J Am Geriats Soc 1993; 41(11):1241-4.
42. Sagnella GA, Markandu ND, Buckley MG, Singer DR, MacGregor GA. Atrial natriuretic peptide-cyclic GMP relationships in normal humans: effects of dietary sodium intake. In: Clin Sci 1993; 85(1):13-17.